US FDA allows expanded use of J&J, Bristol Myers cell therapies

Both J&J and Bristol Myers' therapies helped extend the time that patients lived without disease progression in late stage studies - more than when patients received 'standard of care' treatments, the companies said in separate statements.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/WY37RTi
via